<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="article-commentary" xml:lang="en" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin. Cancer Res.</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC6689131</article-id>
        <article-id pub-id-type="pmcid-ver">PMC6689131.1</article-id>
        <article-id pub-id-type="pmcaid">6689131</article-id>
        <article-id pub-id-type="pmcaiid">6689131</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1038295</article-id>
        <article-id pub-id-type="pmid">30373752</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-18-2293</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1038295</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1038295</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Harding</surname>
              <given-names initials="JJ">James J.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Nandakumar</surname>
              <given-names initials="S">Subhiksha</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Armenia</surname>
              <given-names initials="J">Joshua</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Khalil</surname>
              <given-names initials="DN">Danny N.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Albano</surname>
              <given-names initials="M">Melanie</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ly</surname>
              <given-names initials="M">Michele</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Shia</surname>
              <given-names initials="J">Jinru</given-names>
            </name>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hechtman</surname>
              <given-names initials="JF">Jaclyn F.</given-names>
            </name>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kundra</surname>
              <given-names initials="R">Ritika</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Dika</surname>
              <given-names initials="IE">Imane El</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Do</surname>
              <given-names initials="RK">Richard K.</given-names>
            </name>
            <xref ref-type="aff" rid="A4">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Sun</surname>
              <given-names initials="Y">Yichao</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kingham</surname>
              <given-names initials="TP">T. Peter</given-names>
            </name>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Dâ€™Angelica</surname>
              <given-names initials="MI">Michael I.</given-names>
            </name>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Berger</surname>
              <given-names initials="MF">Michael F.</given-names>
            </name>
            <xref ref-type="aff" rid="A3">3</xref>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hyman</surname>
              <given-names initials="DM">David M.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Jarnagin</surname>
              <given-names initials="W">William</given-names>
            </name>
            <xref ref-type="aff" rid="A6">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Klimstra</surname>
              <given-names initials="DS">David S</given-names>
            </name>
            <xref ref-type="aff" rid="A3">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Janjigian</surname>
              <given-names initials="YY">Yelena Y.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Solit</surname>
              <given-names initials="DB">David B.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
            <xref ref-type="aff" rid="A2">2</xref>
            <xref ref-type="aff" rid="A5">5</xref>
          </contrib>
          <contrib contrib-type="author" equal-contrib="yes">
            <name name-style="western">
              <surname>Schultz</surname>
              <given-names initials="N">Nikolaus</given-names>
            </name>
            <xref ref-type="aff" rid="A2">2</xref>
            <xref ref-type="aff" rid="A5">5</xref>
            <xref ref-type="aff" rid="A7">7</xref>
          </contrib>
          <contrib contrib-type="author" equal-contrib="yes">
            <name name-style="western">
              <surname>Abou-Alfa</surname>
              <given-names initials="GK">Ghassan K.</given-names>
            </name>
            <xref ref-type="aff" rid="A1">1</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Department of Medicine, Memorial Sloan Kettering Cancer Center, New York,New York.</aff>
        <aff id="A2"><label>2</label>Human Oncology and Pathogenesis Program, Memorial Sloan, Kettering Cancer Center, New York, New York.</aff>
        <aff id="A3"><label>3</label>Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.</aff>
        <aff id="A4"><label>4</label>Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.</aff>
        <aff id="A5"><label>5</label>Marie-Jos_ee &amp; Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</aff>
        <aff id="A6"><label>6</label>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</aff>
        <aff id="A7"><label>7</label>Department of Epidemiology &amp; Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.</aff>
        <author-notes>
          <fn fn-type="con" id="FN1">
            <p id="P1">Authorsâ€™ Contributions</p>
            <p id="P2"><bold>Conception and design:</bold> J.J. Harding, J. Armenia, M.I. Dâ€™Angelica, D.S. Klimstra, Y.Y. Janjigian, D.B. Solit, N. Schultz, G.K. Abou-Alfa</p>
            <p id="P3"><bold>Development of methodology:</bold> J.J. Harding, J. Shia, J.F. Hechtman, Y.Y. Janjigian, D.B. Solit, N. Schultz, G.K. Abou-Alfa</p>
            <p id="P4"><bold>Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.):</bold> J.J. Harding, M. Ly, J.F. Hechtman, R.K. Do, T.P. Kingham, M.I. Dâ€™Angelica, D.M. Hyman, W.R. Jarnagin, Y.Y. Janjigian, D.B. Solit, G.K. Abou-Alfa</p>
            <p id="P5"><bold>Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis):</bold> J.J. Harding, S. Nandakumar, J. Armenia, J. Shia, M.F. Berger, D.B. Solit, N. Schultz, G.K. Abou-Alfa</p>
            <p id="P6"><bold>Writing, review, and/or revision of the manuscript:</bold> J.J. Harding, S. Nanda- kumar, J. Armenia, D.N. Khalil, M. Albano, J. Shia, J.F. Hechtman, R. Kundra, I. El Dika, R.K. Do, T.P. Kingham, M.I. Dâ€™Angelica, D.M. Hyman, W.R. Jarnagin, D.S. Klimstra, Y.Y. Janjigian, D.B. Solit, N. Schultz, G.K. Abou-Alfa</p>
            <p id="P7"><bold>Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases):</bold> J.J. Harding, M. Ly, R. Kundra, Y. Sun, D.M. Hyman, Y.Y. Janjigian, D.B. Solit, N. Schultz</p>
            <p id="P8"><bold>Study supervision:</bold> J.J. Harding, D.B. Solit, N. Schultz, G.K. Abou-Alfa</p>
          </fn>
          <fn fn-type="other" id="FN2">
            <p id="P9">N. Schultz and G.K. Abou-Alfa contributed equally to this article.</p>
          </fn>
          <corresp id="CR1"><bold>Corresponding Author:</bold> James J. Harding, Department of Medicine, Memorial, Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065., Phone: 646-888-4314; Fax: 646-888-4255; <email>hardinj1@mskcc.org</email></corresp>
          <fn fn-type="COI-statement" id="FN3">
            <p id="P46">Disclosure of Potential Conflicts of Interest</p>
            <p id="P47">No potential conflicts of interest were disclosed by the other authors.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>29</day>
          <month>10</month>
          <year>2018</year>
        </pub-date>
        <pub-date pub-type="ppub">
          <day>01</day>
          <month>4</month>
          <year>2019</year>
        </pub-date>
        <volume>25</volume>
        <issue>7</issue>
        <issue-id pub-id-type="pmc-issue-id">340180</issue-id>
        <fpage>2116</fpage>
        <lpage>2126</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>25</day>
              <month>07</month>
              <year>2019</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>01</day>
              <month>04</month>
              <year>2020</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>01</day>
              <month>04</month>
              <year>2020</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-16 03:25:13.333">
              <day>16</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1038295.pdf"/>
        <abstract id="ABS1">
          <sec id="S1">
            <title>Purpose:</title>
            <p id="P10">Prior molecular profiling of hepatocellular carcinoma (HCC) has identified actionable findings that may have a role in guiding therapeutic decision-making and clinical trial enrollment. We implemented prospective next-generation sequencing (NGS) in the clinic to determine whether such analyses provide predictive and/or prognostic information for HCC patients treated with contemporary systemic therapies.</p>
          </sec>
          <sec id="S2">
            <title>Experimental Design:</title>
            <p id="P11">Matched tumor/normal DNA from patients with HCC (<italic toggle="yes">N</italic> = 127) were analyzed using a hybridization capture-based NGS assay designed to target 341 or more cancer-associated genes. Demographic and treatment data were prospectively collected with the goal of correlating treatment outcomes and drug response with molecular profiles.</p>
          </sec>
          <sec id="S3">
            <title>Results:</title>
            <p id="P12">WNT/Î²-catenin pathway (45%) and <italic toggle="yes">TP53</italic> (33%) alterations were frequent and represented mutually exclusive molecular subsets. In sorafenib-treated patients (<italic toggle="yes">n</italic> = 81), oncogenic PI3K-mTOR pathway alterations were associated with lower disease control rates (DCR, 8.3% vs. 40.2%), shorter median progression-free survival (PFS; 1.9 vs. 5.3 months), and shorter median overall survival (OS; 10.4 vs. 17.9 months). For patients treated with immune checkpoint inhibitors (<italic toggle="yes">n</italic> = 31), activating alteration WNT/Î²-catenin signaling were associated with lower DCR (0% vs. 53%), shorter median PFS (2.0 vs. 7.4 months), and shorter median OS (9.1 vs. 15.2 months). Twenty-four percent of patients harbored potentially actionable alterations including <italic toggle="yes">TSC1/2</italic> (8.5%) inactivating/truncating mutations, <italic toggle="yes">FGF19</italic> (6.3%) and <italic toggle="yes">MET</italic> (1.5%) amplifications, and <italic toggle="yes">IDH1</italic> missense mutations (&lt;1%). Six percent of patients treated with systemic therapy were matched to targeted therapeutics.</p>
          </sec>
          <sec id="S4">
            <title>Conclusions:</title>
            <p id="P13">Linking NGS to routine clinical care has the potential to identify those patients with HCC likely to benefit from standard systemic therapies and can be used in an investigational context to match patients to genome-directed targeted therapies.</p>
          </sec>
        </abstract>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
